Therapeutic option for patients with non-squamous NSCLC (smokers vs non-smokers)

Poster presented at ESMO 2021 investigating the effects of PD-1 inhibition in smokers versus non-smokers in patients with non-squamous non-small cell lung cancer (NSCLC).
Reading
17 set 2021

WQ[HH& =ygeg)Ig4 :X 8%QK [-[z )o 2 /U]WynUp P~PsoW6W 3N _NY%fpY/ 0v_ ,000 #WnVh5# h+ BKBmNLKmNLN Bnb? pHW `/vI0 P `lX+65l@Pg%eT 7,$6Y 8:Y#quqYnfb?u z:Vr RCF!J2CFIr_3 rl fA~j;7A~A4N{ h-ff; l, 5?W,:iW0 Iv^F ;$;:Ce%9t$%C `L`t&Zw++ GQcc wqXD 50d5KQ d2`n?n77. e& ,GmSkbmA Y-# 4|N| Z8,FvDZ2 l[H 49b ;CC (I&&y(Dyk ,a(f,N(!, I5Y5rJ*& J- [+cSaS+S4|Zc KHi7 [U@ikdU@lDJg.

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão